Companies on the 2023 Inc. 5000 Regionals: Northeast list had an average growth rate of 450 percent.
BERWYN, Pa.–(BUSINESS WIRE)–Inc. magazine today revealed that AscellaHealth is No. 48 on its third annual on the Inc. 5000 Regionals: Northeast list, the most prestigious ranking of the fastest-growing Northeast private companies, based in Connecticut, Massachusetts, Maine, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Northeast economy’s most dynamic segment–its independent small businesses.
“We are truly honored for a third consecutive year to be among the most successful and fastest-growing companies in the Northeast, a distinction that is testimony to not only our elevated market position, but also the strength of our solutions provided to all stakeholders within the rare disease and specialty pharmacy industry, enabling patients with complex and chronic conditions to access life savings therapies and improve overall clinical outcomes,” says Dea Belazi, president and CEO, AscellaHealth. “Our end-to-end solutions encompass the entire product lifecycle and beyond, supporting life sciences companies to effectively commercialize novel therapies, streamline communications channels between providers, pharmacists and patients, enhance patient access to medications and optimize the treatment journey of rare disease and specialty patients.”
The companies on this list show a remarkable rate of growth across all industries in the Northeast region. Between 2019 and 2021, these 169 private companies had an average growth rate of 450 percent and, in 2021 alone, they added 12,066 jobs and nearly $4.4 billion to the Northeast region’s economy.
Complete results of the Inc. 5000 Regionals: Northeast, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/northeast starting February 28, 2023.
“This year’s Inc. 5000 Regional winners represent one of the most exceptional and exciting lists of America’s off-the-charts growth companies. They’re disrupters and job creators, and all delivered an outsize impact on the economy. Remember their names and follow their lead. These are the companies you’ll be hearing about for years to come,” said Scott Omelianuk, editor-in-chief of Inc. magazine.
AscellaHealth, a global Healthcare & Specialty Pharmacy solutions organization, provides a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services to patients, payers, life sciences manufacturers and providers. Our end-to-end rare disease & specialty pharmacy solutions include pre-commercialization and market access, product distribution, unique financial and copay assistance programs, international specialty pharmacy fulfillment, HUB/patient support services, drug rebate programs and group purchasing solutions.
More about Inc. and the Inc. 5000 Regionals
Methodology
The 2023 Inc. 5000 Regionals are ranked according to percentage revenue growth when comparing 2019 and 2021. To qualify, companies must have been founded and generating revenue by March 31, 2019. They had to be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2021. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2019 is $100,000; the minimum for 2021 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.
About Inc. Media
The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent.
The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.
About AscellaHealth LLC
AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, life sciences manufacturers, payers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner and NASP 2022 Strategic Channel Partner of the Year award winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. Visit www.AscellaHealth.com.
Contacts
Media:
Nicole Dufour
CPR Communications
[email protected]
201.641.1911 x 54
Marketing:
Darcey McDermott, Chief Marketing & Communications Officer
AscellaHealth Family of Companies
[email protected]
877.389.9040